Vanta Bioscience

Vanta Bioscience FCF per Share

The Free Cash Flow per Share of Vanta Bioscience (540729.BO) as of Oct 18, 2026 is -14.42 INR. In the previous year, Free Cash Flow per Share was -1.14 INR — a change of 1,162.94% (lower).

FCF per Share

-14.42INR

YoY

1,162.94%

Last updated:

Free Cash Flow per Share of Vanta Bioscience is 2025 -14.42 INR. Free Cash Flow per Share of Vanta Bioscience was 2024 -1.14 INR. It decreases by 1,162.94% lower compared to the previous year.

The Vanta Bioscience FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2019
-5.93 INR
Jan 1, 2020
-8.31 INR
Jan 1, 2021
-24.28 INR
Jan 1, 2022
-18.95 INR
Jan 1, 2023
-46.45 INR
Jan 1, 2024
-1.14 INR
Jan 1, 2025
-14.42 INR
The Vanta Bioscience FCF per Share history
YEARFCF per ShareYoY
-14.42INR+1,162.94%
-1.14INR-97.54%
-46.45INR+145.15%
-18.95INR-21.97%
-24.28INR+192.14%
-8.31INR+40.11%
-5.93INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vanta Bioscience Stock analysis

What does Vanta Bioscience do? Vanta Bioscience Ltd is a company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Headquartered in Secunderabad, India, the company provides preclinical contract research services. It went public through an IPO on October 6, 2017. Vanta Bioscience offers a range of services including testing and contract research in clinical research, pre-clinical research, biopharma services, analytical testing, and environmental studies. The company serves clients from various industries such as pharmaceuticals, medical devices, nutraceuticals, feed additives, biotechnology, agrochemicals, cosmetics, and chemicals. Their services include preclinical safety assessment, risk assessment for active pharmaceutical ingredients (APIs), excipients, extractables and leachables, and pharmaceutical impurities. Additionally, Vanta Bioscience provides services for determining health-based exposure limits, such as permitted daily exposure (PDE) or allowable daily exposure (ADE), as well as occupational exposure limits (OEL) for pharmaceutical manufacturers. The company's website is www.vantabio.com. Vanta Bioscience Ltd is listed on the Bombay Stock Exchange under the ticker 540729.BO and has the ISIN INE695X01011. The company focuses on delivering comprehensive preclinical research solutions to support the development and safety evaluation of products across multiple sectors. Vanta Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vanta Bioscience stock

Free Cash Flow per Share of Vanta Bioscience is -14.42 INR in 2025.

Free Cash Flow per Share of Vanta Bioscience changed from -1.14 INR to -14.42 INR, representing a 1,162.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Vanta Bioscience since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Vanta Bioscience

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Vanta Bioscience